ST交昂(600530) - 2016 Q1 - 季度财报

Financial Performance - Operating revenue for the quarter was ¥86,817,815.06, reflecting a year-on-year growth of 1.13%[7] - Net profit attributable to shareholders of the listed company was ¥30,822,110.50, up 3.48% from the previous year[7] - Basic earnings per share increased to ¥0.099, representing a growth of 3.48% year-on-year[7] - Total revenue for Q1 2016 was CNY 91,152,022.96, a slight increase of 1.14% compared to CNY 90,128,471.44 in the same period last year[29] - Operating income for Q1 2016 was CNY 86,817,815.06, up from CNY 85,844,008.74, reflecting a growth of 1.13% year-over-year[29] - Net profit for Q1 2016 reached CNY 31,341,433.41, representing an increase of 1.35% from CNY 30,924,117.47 in the previous year[30] Cash Flow - The net cash flow from operating activities was -¥29,252,742.86, a significant decrease of 227.94% compared to the same period last year[7] - Cash inflow from operating activities totaled ¥87,882,854.93, a decrease of 25.4% from ¥117,807,907.59 in the previous period[34] - Cash inflow from investment activities was ¥41,227,717.59, down from ¥46,077,358.73 in the previous period[34] - Net cash flow from investment activities was -¥271,733,573.82, compared to a positive ¥23,602,992.49 in the prior period[34] - Cash inflow from financing activities amounted to ¥536,750,000.00, with a net cash flow of ¥461,558,109.71, a significant improvement from -¥67,961,919.24 in the previous period[35] - The company reported a net increase in cash and cash equivalents of ¥160,095,627.10, contrasting with a decrease of ¥53,276,457.38 in the previous period[35] Assets and Liabilities - Total assets at the end of the reporting period reached ¥2,941,313,855.17, an increase of 9.42% compared to the previous year[7] - Current assets rose to 693,857,903.31 TL, up from 494,140,552.04 TL, indicating a significant increase of about 40.5%[25] - Total liabilities rose to 1,133,607,898.46 TL from 726,678,589.74 TL, showing an increase of approximately 56.1%[27] - Owner's equity decreased to 1,807,705,956.71 TL from 1,961,358,558.23 TL, a decline of about 7.8%[27] Shareholder Information - The total number of shareholders at the end of the reporting period was 37,458[12] - The largest shareholder, Dazhong Transportation Group, held 18.36% of the shares[12] - The company did not issue any preferred shares during the reporting period[13] Expenses - Sales expenses decreased by 34.97% to 26,816,694.74 from 41,239,760.32, mainly due to reduced promotional and advertising costs in the health product sector[16] - Financial expenses increased by 114.78% to 5,896,210.75 from 2,745,183.49, driven by increased interest expenses from short-term bank loans[16] Investments - The company acquired a 4.81% stake in Tai Ling Pharmaceutical for 200 million HKD, with an average purchase price not exceeding 2.50 HKD per share[20] - The company completed the purchase of a new office property in Shanghai for a total price of 28,012,020 RMB, with a building area of 1,451.4 square meters[21] Other Financial Metrics - The weighted average return on net assets improved by 0.35 percentage points to 1.76%[7] - Non-recurring gains and losses included a net profit of ¥26,009,279.18 from financial assets and liabilities[9] - The company experienced a significant loss in other comprehensive income, amounting to CNY -186,744,034.93, compared to a gain of CNY 30,166,670.00 in the same period last year[32] - The total comprehensive income for Q1 2016 was CNY -169,484,116.80, a decrease from CNY 57,155,619.21 in the previous year[32]